WHA74

A century after the discovery of insulin, quality-assured access remains hindered by high prices. The WHO resolution for transparency in pricing of insulin aims at dealing with Big Pharma market monopoly

The 74th World Health Assembly that began on Monday will have to deal with a host of challenges at a time when the COVID-19 pandemic has exposed the stark inequalities in every aspect of health across the globe